Lung Cancer Awareness Month 2023
post-1200-x-630-px-copy-v97qa1.jpg)
Lung Cancer Awareness Month 2023
November is globally recognized as Lung Cancer Awareness Month, a time dedicated to raising awareness about the leading cause of cancer deaths worldwide. As a clinical research organization, we are at the forefront of the fight against lung cancer, and we understand the importance of early detection, innovative treatments, and patient education. This article delves into the significance of this month from a clinical research perspective.
Lung cancer remains one of the most diagnosed cancers globally. Despite advancements in medical science, the survival rate for late-stage lung cancer remains low, emphasizing the critical need for early detection and intervention.
Types of Lung Cancer: The two primary types are Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC). NSCLC accounts for about 85% of all cases, while SCLC, although less common, is more aggressive.
Risk Factors: Smoking remains the leading risk factor, but exposure to asbestos, air pollutants and other environmental factors also play a role. Genetics and family history can also increase susceptibility.
Our organization is involved in clinical trials aimed at finding more effective treatments and improving patient outcomes. Here's how:
Innovative Therapies: We are researching targeted therapies and immunotherapies that can specifically attack cancer cells without harming healthy cells. These treatments aim to increase the effectiveness of treatment while reducing side effects.
Early Detection: We're investing in studies that focus on early detection methods, including advanced imaging techniques and biomarker tests. Early detection can significantly improve survival rates.
Patient-centered Trials: Recognizing that every patient is unique, we're moving towards more personalized medicine approaches. Our trials are designed to consider individual genetic makeup, lifestyle, and other factors.
By educating the public about the risks, symptoms, and importance of early detection, we can save lives. At Accellacare, we are committed to understanding diagnosis and treatment of lung cancer. If you are a healthy individual that has not had a cancer diagnosis, click here to learn more about our clinical trials which are aimed at advancing existing cancer diagnoses.
